Expression of PD-L1 has been reported in several carcinomas including non-small cell lung cancer, melanoma, and head and neck squamous cell carcinoma (HNSCC), however with a diverse effect on survival [14,15,16]. Here, CD274 is linked to head and neck squamous cell carcinoma.